SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canada's Medicenna Therapeutics Q2 net loss narrows on lower costs

Canada's Medicenna Therapeutics Q2 net loss narrows on lower costs Overview Canada immunotherapy fir

Related stories